Kolganova, M.A.; Melnik, E.V.; Fisher, E.N.; Smirnov, V.V.; Vlasov, A.M.; Gegechkori, V.I.; Shulga, N.A.; Shokhin, I.E.; Ramenskaya, G.V.
Affinity Capture Elution (ACE) ELISA Method Development and Validation for Novel RPH-104 Drug Immunogenicity Evaluation. Biomedicines 2022, 10, 2750.
https://doi.org/10.3390/biomedicines10112750
AMA Style
Kolganova MA, Melnik EV, Fisher EN, Smirnov VV, Vlasov AM, Gegechkori VI, Shulga NA, Shokhin IE, Ramenskaya GV.
Affinity Capture Elution (ACE) ELISA Method Development and Validation for Novel RPH-104 Drug Immunogenicity Evaluation. Biomedicines. 2022; 10(11):2750.
https://doi.org/10.3390/biomedicines10112750
Chicago/Turabian Style
Kolganova, Maria A., Elizaveta V. Melnik, Elizaveta N. Fisher, Valery V. Smirnov, Alexander M. Vlasov, Vladimir I. Gegechkori, Nikolay A. Shulga, Igor E. Shokhin, and Galina V. Ramenskaya.
2022. "Affinity Capture Elution (ACE) ELISA Method Development and Validation for Novel RPH-104 Drug Immunogenicity Evaluation" Biomedicines 10, no. 11: 2750.
https://doi.org/10.3390/biomedicines10112750
APA Style
Kolganova, M. A., Melnik, E. V., Fisher, E. N., Smirnov, V. V., Vlasov, A. M., Gegechkori, V. I., Shulga, N. A., Shokhin, I. E., & Ramenskaya, G. V.
(2022). Affinity Capture Elution (ACE) ELISA Method Development and Validation for Novel RPH-104 Drug Immunogenicity Evaluation. Biomedicines, 10(11), 2750.
https://doi.org/10.3390/biomedicines10112750
